Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Abstract BNT162b2 vaccine, developed by BioNTech and Pfizer ha recently approved for use in children aged 5 to 11 years. Recent data show evidence of safety on the administration and serious adverse events have been rarely reported. However, allergic systemic reactions could occur. In some cases, a...
保存先:
主要な著者: | Elio Novembre (著者), Mariangela Tosca (著者), Carlo Caffarelli (著者), Mauro Calvani (著者), Fabio Cardinale (著者), Riccardo Castagnoli (著者), Elena Chiappini (著者), Claudio Cravidi (著者), Michele Miraglia Del Giudice (著者), Marzia Duse (著者), Amelia Licari (著者), Sara Manti (著者), Alberto Martelli (著者), Giampaolo Ricci (著者), Giuseppe Pingitore (著者), Gian Luigi Marseglia (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
BMC,
2022-05-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Record of strep throat infections in Italy: what is needed to know about penicillin allergy? The point of view from the Italian Society of Pediatric Allergy and Immunology (SIAIP)
著者:: Maria De Filippo, 等
出版事項: (2024) -
Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology
著者:: E. Chiappini, 等
出版事項: (2019) -
Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: a joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP)
著者:: Roberto Berni Canani, 等
出版事項: (2022) -
Allergic rhinitis management: a Delphi Consensus promoted by the Italian Society of Pediatric Allergy and Immunology (SIAIP)
著者:: Michele Miraglia del Giudice, 等
出版事項: (2024) -
Monoclonal antibodies in pediatric allergy
著者:: Amelia Licari, 等
出版事項: (2015)